Kura Oncology Inc. (NASDAQ: KURA) open the trading on May 25, 2023, with a bit cautious approach as it glided -1.00% to $13.85. During the day, the stock rose to $14.02 and sunk to $13.30 before settling in for the price of $13.99 at the close. Taking a more long-term approach, KURA posted a 52-week range of $9.49-$19.93.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
Meanwhile, its Annual Earning per share during the time was -5.90%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -3.10%. This publicly-traded company’s shares outstanding now amounts to $68.40 million, simultaneously with a float of $64.56 million. The organization now has a market capitalization sitting at $908.84 million. At the time of writing, stock’s 50-day Moving Average stood at $11.81, while the 200-day Moving Average is $13.34.
Kura Oncology Inc. (KURA) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Kura Oncology Inc.’s current insider ownership accounts for 1.94%, in contrast to 106.44% institutional ownership. According to the most recent insider trade that took place on Jan 27, this organization’s Chief Medical Officer sold 9,225 shares at the rate of 13.88, making the entire transaction reach 128,033 in total value, affecting insider ownership by 27,675. Preceding that transaction, on Jan 27, Company’s CCO & Chief Strategy Officer sold 1,906 for 13.89, making the whole transaction’s value amount to 26,474. This particular insider is now the holder of 20,605 in total.
Kura Oncology Inc. (KURA) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 3/30/2023 suggests? It has posted -$0.5 earnings per share (EPS) beating the forecaster’s viewpoint (set at -$0.54) by $0.04. This company achieved a return on equity of -29.31. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.61 per share during the current fiscal year.
Kura Oncology Inc.’s EPS decrease for this current 12-month fiscal period is -3.10% and is forecasted to reach -2.28 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 19.93% through the next 5 years, which can be compared against the -5.90% growth it accomplished over the previous five years trading on the market.
Kura Oncology Inc. (NASDAQ: KURA) Trading Performance Indicators
Let’s observe the current performance indicators for Kura Oncology Inc. (KURA). It’s Quick Ratio in the last reported quarter now stands at 21.70. The Stock has managed to achieve an average true range (ATR) of 0.73.
In the same vein, KURA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.04, a figure that is expected to reach -0.56 in the next quarter, and analysts are predicting that it will be -2.28 at the market close of one year from today.
Technical Analysis of Kura Oncology Inc. (KURA)
[Kura Oncology Inc., KURA] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 86.02% While, its Average True Range was 0.76.
Raw Stochastic average of Kura Oncology Inc. (KURA) in the period of the previous 100 days is set at 78.35%, which indicates a major fall in contrast to 85.86% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 43.63% that was lower than 47.94% volatility it exhibited in the past 100-days period.